A Health Affairs study challenges conventional wisdom and finds physicians who have electronic access to previous imaging results are actually more likely to order additional tests.
A major impetus behind adoption of electronic health records has been the reasoning that they could help reduce healthcare spending, in part, by reducing redundant imaging tests.
But a study published in Health Affairs challenges that conventional wisdom: Researchers found physicians who have electronic access to previous imaging results are actually more likely to order additional tests.
Access to computerized imaging results was associated with a 40 percent to 70 percent greater likelihood that an office-based physician will order an imaging test, according to researchers from Harvard-affiliated Cambridge Health Alliance in Cambridge, Mass., and the City University of New York School of Public Health at Hunter College in New York. Access to lab results was also associated with ordering more blood tests.
The availability of the EHR itself had no apparent impact on order; it was access to test results, researchers said. They analyzed the records of 28,741 patient visits to a nationally representative sample of 1,187 office-based physicians in 2008.
The researchers said the federal government’s effort to promote widespread EHR use “may not yield anticipated cost savings from reductions in duplicative or inappropriate diagnostic testing.”
“These findings raise the possibility that, as currently implemented, electronic access does not decrease test ordering in the office setting and may even increase it, possibly because of system features that are enticements to ordering,” the authors wrote. “We conclude that use of these health information technologies, whatever their other benefits, remains unproven as an effective cost-control strategy with respect to reducing the ordering of unnecessary tests.”
Their findings run contrary to other studies that have found access to prior images reduces repeat ordering and thus saves billions of dollars. However, researchers said previous studies were based on “flagship” institutions, not representative of office-based practices and technology.
One caveat here is that the study is based on 2008 data, when fewer physicians used EHRs and shared imaging and other patient data. Second, the study doesn’t tell us why access led to more tests ordered.
Study author Danny McCormick tells the WSJ Health Blog that although their research doesn’t point to a reason, they have some ideas, including that if doctors know an image result will conveniently show up on the screen, they may be more inclined to order the test. Or doctors who order more imaging studies are more likely to have health IT on which to view the studies, he said.
Finally, he said that the results don’t determine whether the imaging tests are appropriate or not.
What do you think of this study?
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.